The initiation of an antitrust investigation by the Justice Department into UnitedHealth is a significant legal challenge that can lead to regulatory scrutiny, potential fines, or restrictions on business practices. Such investigations typically create uncertainty around the company's future operations and profitability, leading to negative investor sentiment and a decrease in stock price in the short term.